Literature DB >> 15126002

Quantitative ultrasound of proximal phalanxes in patients with type 1 diabetes mellitus.

Giuliana Valerio1, Antonio del Puente, Pietro Buono, Antonella Esposito, Manuela Zanatta, Enza Mozzillo, Erika Moretto, Loredana Mastidoro, Adriana Franzese.   

Abstract

The influence of duration of diabetes and metabolic control on phalangeal quantitative ultrasound (QUS) was evaluated in a group of children and adolescents with type 1 diabetes. Eighty-six patients (mean age 11.9 years; mean duration 4.3 years) were studied. Daily calcium intake was assessed by means of a questionnaire. Amplitude-dependent speed of sound (AD-SoS) was measured at the phalanxes of the non-dominant hand and expressed as a z-score. Linear and multivariate correlations with duration of diabetes and, short term and long term metabolic control were sought. AD-SoS z-score was -0.43+/-1.4 (95% CI, -0.73; -0.13). Nine subjects had values below -2S.D. Daily calcium intake was 1042+/-456 mg/day; 47 subjects (54.6%) were below the recommended levels. A negative correlation was found between AD-SoS z-score and duration (r, -0.33, P=0.002) or metabolic control (HbA1c-last year r, -0.32, P=0.002; HbA1c-whole duration, r, -0.40; P=0.003). Negative AD-SoS z-scores depended significantly and directly on duration and quality of metabolic control, even when controlled for calcium intake. In conclusion, the architectural organization of bone was impaired in 10.5% patients. Duration of diabetes and poor metabolic control were the main determinants affecting AD-SoS. QUS may be a useful tool in the screening of bone disturbance in young patients with diabetes. Optimization of metabolic control is required to prevent osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126002     DOI: 10.1016/j.diabres.2003.10.021

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  Bone status in adolescents with type 1 diabetes.

Authors:  A P Chobot; A Haffke; J Polanska; Z P Halaba; G Deja; P Jarosz-Chobot; W Pluskiewicz
Journal:  Diabetologia       Date:  2010-05-09       Impact factor: 10.122

Review 2.  Celiac disease in type 1 diabetes mellitus.

Authors:  Maria Erminia Camarca; Enza Mozzillo; Rosa Nugnes; Eugenio Zito; Mariateresa Falco; Valentina Fattorusso; Sara Mobilia; Pietro Buono; Giuliana Valerio; Riccardo Troncone; Adriana Franzese
Journal:  Ital J Pediatr       Date:  2012-03-26       Impact factor: 2.638

3.  Phalangeal quantitative ultrasound in 1,719 children and adolescents with bone disorders.

Authors:  A Mussa; F Porta; G Baldassarre; G Tuli; F de Terlizzi; P Matarazzo; S Einaudi; R Lala; A Corrias
Journal:  Osteoporos Int       Date:  2011-09-23       Impact factor: 4.507

4.  Phalangeal quantitative ultrasound and metabolic control in pre-menopausal women with type 1 diabetes mellitus.

Authors:  A Catalano; N Morabito; G Di Vieste; B Pintaudi; D Cucinotta; A Lasco; A Di Benedetto
Journal:  J Endocrinol Invest       Date:  2012-10-01       Impact factor: 4.256

Review 5.  Evidence-based outcomes on diagnostic accuracy of quantitative ultrasound for assessment of pediatric osteoporosis - a systematic review.

Authors:  Kuan Chung Wang; Kuan Chieh Wang; Afsaneh Amirabadi; Edward Cheung; Elizabeth Uleryk; Rahim Moineddin; Andrea S Doria
Journal:  Pediatr Radiol       Date:  2014-06-25

Review 6.  Calcium supplementation for improving bone mineral density in children.

Authors:  T M Winzenberg; K Shaw; J Fryer; G Jones
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

7.  The correlation between phalangeal quantitative ultrasonography and dual energy x-ray absorptiometry in women with premature ovarian failure.

Authors:  Tandip S Mann; Alison H McGregor; Rajesh Patel
Journal:  Mcgill J Med       Date:  2008-07

8.  Young women with type 1 diabetes have lower bone mineral density that persists over time.

Authors:  Lucy D Mastrandrea; Jean Wactawski-Wende; Richard P Donahue; Kathleen M Hovey; Angela Clark; Teresa Quattrin
Journal:  Diabetes Care       Date:  2008-06-30       Impact factor: 19.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.